Trials / Completed
CompletedNCT01545856
Cardiovascular Events in Parkinson's Disease Patients
Background Incidence of Cardiovascular Ischaemic Events in Treated Parkinson's Disease Patients in the Impact Database
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Cardiovascular (CV) disease is a common comorbidity of Parkinson's disease (PD). The background incidence rate of CV events in a levodopa-treated PD population was assessed to better understand these comorbidities in the PD population. One objective of the study is to identify a population of prevalent PD patients with incident levodopa use within the years 2004-2010 on the Integrated Health Care Information Services (IHCIS) database. The second objective is to report the incidence of CV events overall and during intervals 0-6, 6-12 and 12-18 months after first prescription of levodopa among all new levodopa users.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levodopa | levodopa use |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2012-03-07
- Last updated
- 2017-05-16
Source: ClinicalTrials.gov record NCT01545856. Inclusion in this directory is not an endorsement.